From the current issue
What does this mean in 2013?
Active surveillance has become a trusted choice for many men with low-risk cancer
Techniques differ but all aim for the same goals
Between standard therapy and active surveillance: are there other choices?
Radiation therapy then, now and in the future
The history of ADT, its current uses and a glimpse into the future
New therapies give men a whole new outlook
News and updates
One man's story
Readers are asking
Download past issues
We want to hear from you! Click here to send us your comments, questions
or stories.
Content of Our Voice is guided by Co-editors in Chief Dr. John Trachtenberg and Dr. Simon Tanguay and an Editorial board composed of Canadian experts.
Our Voice is endorsed by the Prostate Cancer Canada Network and the Canadian Urological Association.
OurVoice Sponsors
